Lubrizol Acquires Bavaria Medizin Technologie GmbH

CLEVELAND, July 15 (Bernama-GLOBE NEWSWIRE) — The Lubrizol Corporation announces the acquisition of Bavaria Medizin Technologie GmbH (BMT), an innovative designer and manufacturer of both intravascular (coronary, peripheral, and cranial) and nonvascular devices, including drug-coated balloons, by its German subsidiary Lubrizol Deutschland GmbH from its current majority shareholder Custos Vermögensverwaltungs GmbH as well as from the minority shareholders.

http://mrem.bernama.com/viewsm.php?idm=34996